Related Experiment Video
Updated: Jul 7, 2025

Synthesis of Protein Bioconjugates via Cysteine-maleimide Chemistry
Published on: July 20, 2016
Chemoselective umpolung of thiols to episulfoniums for cysteine bioconjugation
Philipp Hartmann1,2, Kostiantyn Bohdan1,2, Moritz Hommrich1,2
1Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany.
Abstract:
Cysteine conjugation is an important tool in protein research and relies on fast, mild and chemoselective reactions. Cysteinyl thiols can either be modified with prefunctionalized electrophiles, or converted into electrophiles themselves for functionalization with selected nucleophiles in an independent step. Here we report a bioconjugation strategy that uses a vinyl thianthrenium salt to transform cysteine into a highly reactive electrophilic episulfonium intermediate in situ, to enable conjugation with a diverse set of bioorthogonal nucleophiles in a single step. The reactivity profile can connect several nucleophiles to biomolecules through a short and stable ethylene linker, ideal for introduction of infrared labels, post-translational modifications or NMR probes. In the absence of reactive exogenous nucleophiles, nucleophilic amino acids can react with the episulfonium intermediate for native peptide stapling and protein-protein ligation. Ready synthetic access to isotopologues of vinyl thianthrenium salts enables applications in quantitative proteomics. Such diverse applications demonstrate the utility of vinyl-thianthrenium-based bioconjugation as a fast, selective and broadly applicable tool for chemical biology.
More Related Videos
Related Concept Videos
Preparation and Reactions of Thiols
Preparation and Reactions of Sulfides
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
Structure and Nomenclature of Thiols and Sulfides
Electrophilic Aromatic Substitution: Sulfonation of Benzene
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...

